Renal complications following heart transplantation in children: A single-center study

American Journal of Transplantation

Volumn 3, Issue 2, 2003, Pages 214-218

  Phan, Véronique ^a   West, Lori J ^a   Stephens, Derek ^a   Hébert, Diane ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Heart transplantation; Renal complications

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; AGE; ANALYSIS OF VARIANCE; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GROWTH; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY DYSFUNCTION; MALE; PEDIATRIC SURGERY; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADOLESCENT; CALCINEURIN; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GROWTH; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; INCIDENCE; INFANT; KIDNEY DISEASES; MALE; ONTARIO; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037296535     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00045.x     Document Type: Article

References (21)

1. Le Bidois LKJ, Vouhé P, Sidi D, Tamisier D. Heart transplantation in children, mid-term results and quality of life. Eur J Pediatr 1992; 151 (Suppl. 1): S59-64.
2. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699-705.
3. Greenberg A, Thompson ME, Griffith BJ et al. Cyclosporine nephrotoxicity in cardiac allograft patients - a seven-year followup. Transplantation 1990; 50: 589-593.
4. Griffiths MH, Crowe AV, Papadaki L et al. Cyclosporin nephrotoxicity in heart and lung transplant patients. Q J Med 1996; 89: 751-763.
5. Gonwa TA, Mai ML, Pilcher J et al. Stability of long-term renal function in heart transplant patients treated with induction therapy and low-dose cyclosporine. J Heart Lung Transplant 1992; 11: 926-928.
6. Lloveras JJ, Durand D, Ader JL et al. Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period. Transplant Proc 1993; 25: 2226.
7. Ruggenenti P, Perico N, Amuchastegui CS, Ferrazzi P, Mamprin F, Remuzzi. Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine. Am J Kidney Dis 1994; 24: 549-553.
8. Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen DJ. Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995; 26: 193-201.
9. Bunke M, Sloan R, Brier M, Ganzel B. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing (see comments). Transplantation 1995; 59: 537-540.
10. Waser MMM, Binswanger U, Keusch G et al. Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. J Heart Lung Transpl 1993; 12: 846-850.
11. Reichart B, Meiser B, Vigano M et al. European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results European Tacrolimus Multicenter Heart Study Group. J Heart Lung Transplant 1998; 17: 775-781.
12. Taylor DO, Barr ML, Radovancevic B et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999; 18: 336-345.
13. Robitaille P, Chartrand S, Stanley P, Chartrand C. Long-term assessment of renal function under cyclosporine in pediatric heart transplant recipients. J Heart Lung Transplant 1991; 10: 460-462; Discussion 463.
14. Haverish AHS, Wagenbreth I, Luhmer I, Ziemer G, Kallfelz HC. Thoracic organ transplantation in pediatric group, the Hannover experience. Eur J Pediatr 1992; 151 (Suppl. 1): S65-69.
15. Asante-Korang A, Boyle GJ, Webber SA, Miller SA, Fricker FJ. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. J Heart Lung Transplant 1996; 15: 415-422.
16. Schwartz GBL, Spitzer A. The use of creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571-590.
17. Billingham ME, Cary NR, Hammond ME et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587-593.
18. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996; 98 (4 Part 1): 649-658.
19. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
20. Centers for Disease Control and Prevention, National Center for Health Statistics. CDC growth charts: United States. http:// www.cdc.gov/growthcharts/ May 30, 2000.
21. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D. Cyclosporine-associated end-stage nephropathy after cardiac: transplantation, incidence and progression. Transplantation 1997; 63: 664-668.